US5993805A
(en)
*
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6395494B1
(en)
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
US5770609A
(en)
*
|
1993-01-28 |
1998-06-23 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
DE4242863A1
(de)
*
|
1992-12-18 |
1994-06-23 |
Boehringer Mannheim Gmbh |
Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5595722A
(en)
*
|
1993-01-28 |
1997-01-21 |
Neorx Corporation |
Method for identifying an agent which increases TGF-beta levels
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6663881B2
(en)
*
|
1993-01-28 |
2003-12-16 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5354934A
(en)
†
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
ATE406909T1
(de)
*
|
1993-05-13 |
2008-09-15 |
Poniard Pharmaceuticals Inc |
Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
|
US6197789B1
(en)
|
1995-06-07 |
2001-03-06 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US5457044A
(en)
*
|
1993-10-29 |
1995-10-10 |
Genentech, Inc. |
Method for collection of aerosolized proteins by inert filtration
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
WO1995024183A1
(en)
*
|
1994-03-07 |
1995-09-14 |
Inhale Therapeutic Systems |
Methods and compositions for pulmonary delivery of insulin
|
EP0759939B1
(de)
|
1994-05-18 |
2005-07-20 |
Nektar Therapeutics |
Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US5580856A
(en)
*
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
JP4155594B2
(ja)
|
1994-12-22 |
2008-09-24 |
アストラゼネカ・アクチエボラーグ |
エアゾール製剤
|
PL321094A1
(en)
|
1994-12-22 |
1997-11-24 |
Astra Ab |
Parathyroid hormone (pth) containing preparation administered by inhalation
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US5556771A
(en)
*
|
1995-02-10 |
1996-09-17 |
Gen-Probe Incorporated |
Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
|
AU706195B2
(en)
*
|
1995-04-14 |
1999-06-10 |
Inhale Therapeutic Systems |
Powdered pharmaceutical formulations having improved dispersibility
|
US6165463A
(en)
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US6019968A
(en)
*
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5875776A
(en)
*
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5876992A
(en)
*
|
1996-07-03 |
1999-03-02 |
Molecular Biology Resources, Inc. |
Method and formulation for stabilization of enzymes
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
IE970801A1
(en)
*
|
1997-11-11 |
1999-05-19 |
Helsinn Chemicals Ireland Ltd |
An apparatus for producing a pharmaceutical product
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
US6451349B1
(en)
*
|
1998-08-19 |
2002-09-17 |
Quadrant Healthcare (Uk) Limited |
Spray-drying process for the preparation of microparticles
|
US6907679B2
(en)
*
|
1998-11-12 |
2005-06-21 |
Qlt Usa, Inc. |
Method for lyophilizing an active agent
|
EP2280004B1
(de)
*
|
1999-06-29 |
2016-04-20 |
MannKind Corporation |
Pharmazeutische zusammensetzungen enthaltend insulin komplexiert mit diketopiperazin
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7029700B2
(en)
*
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
WO2001052818A1
(en)
|
2000-01-19 |
2001-07-26 |
Pharmaceutical Discovery Corporation |
Dry powder formulations of antihistamine for nasal administration
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
MXPA02001323A
(es)
|
2000-05-10 |
2004-07-16 |
Alliance Pharma |
Microgranulos con base fosfolipida para la liberacion de farmaco.
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
GB0027357D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
DK1429731T3
(da)
*
|
2001-09-19 |
2007-05-14 |
Elan Pharma Int Ltd |
Nanopartikelformuleringer indeholdende insulin
|
MXPA04004730A
(es)
*
|
2001-11-19 |
2004-07-30 |
Becton Dickinson Co |
Composiciones farmaceuticas en forma particulada.
|
CA2468958C
(en)
|
2001-12-19 |
2012-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
US20040077540A1
(en)
*
|
2002-06-28 |
2004-04-22 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
|
DE10234165B4
(de)
*
|
2002-07-26 |
2008-01-03 |
Advanced Micro Devices, Inc., Sunnyvale |
Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
|
US20050181059A1
(en)
*
|
2003-09-30 |
2005-08-18 |
Spherics, Inc. |
Nanoparticulate therapeutic biologically active agents
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
AU2005204378B2
(en)
*
|
2004-01-12 |
2009-01-22 |
Mannkind Corporation |
A method of reducing serum proinsulin levels in type 2 diabetics
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
JP5078014B2
(ja)
|
2004-08-20 |
2012-11-21 |
マンカインド コーポレイション |
ジケトピペラジン合成の触媒反応
|
MX2007002189A
(es)
|
2004-08-23 |
2008-01-11 |
Mannkind Corp |
Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
|
WO2006078841A1
(en)
*
|
2005-01-21 |
2006-07-27 |
President And Fellows Of Harvard College |
Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles
|
JP2009500163A
(ja)
*
|
2005-07-07 |
2009-01-08 |
ナノセラピューティクス・インコーポレイテッド |
粉末を製粉および調製する方法及びそれにより得られる組成物
|
US7803404B2
(en)
|
2005-09-14 |
2010-09-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
IN2015DN00888A
(de)
|
2006-02-22 |
2015-07-10 |
Mannkind Corp |
|
MX2008013165A
(es)
|
2006-04-12 |
2009-01-29 |
Biodel Inc |
Formulaciones de combinacion de insulina de accion rapida y accion larga.
|
JP5373618B2
(ja)
*
|
2006-11-02 |
2013-12-18 |
オムリクス バイオファーマシューティカルズ リミテッド |
微粒化方法
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
KR100947290B1
(ko)
|
2007-06-13 |
2010-03-16 |
이희영 |
케라틴을 주성분으로 하는 인체 부속기관을 이용한 인체부피 대체용 또는 세포 배양용 지지체 및 그 제조방법
|
CA3123813A1
(en)
|
2007-12-04 |
2009-06-11 |
Biogen Chesapeake Llc |
Improved glibenclamide formulations and methods for lyophilization thereof and lyophilates provided thereby
|
KR101933816B1
(ko)
|
2008-06-13 |
2019-03-29 |
맨카인드 코포레이션 |
건조 분말 흡입기 및 약물 투여 시스템
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
WO2009155581A1
(en)
|
2008-06-20 |
2009-12-23 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
US8399018B2
(en)
*
|
2008-07-21 |
2013-03-19 |
Otonomy, Inc. |
Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
BRPI1013154B1
(pt)
|
2009-06-12 |
2020-04-07 |
Mannkind Corp |
Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
MX359281B
(es)
|
2010-06-21 |
2018-09-21 |
Mannkind Corp |
Sistema y metodos para suministrar un farmaco en polvo seco.
|
MX350838B
(es)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Composicion de sal.
|
MX353285B
(es)
|
2011-04-01 |
2018-01-05 |
Mannkind Corp |
Paquete de blister para cartuchos farmaceuticos.
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
IN2014DN03093A
(de)
|
2011-10-24 |
2015-05-15 |
Mannkind Corp |
|
KR102196009B1
(ko)
|
2011-10-25 |
2021-01-04 |
프로테나 바이오사이언시즈 리미티드 |
항체 제형 및 방법
|
SG10201605800UA
(en)
|
2012-07-12 |
2016-09-29 |
Mannkind Corp |
Dry powder drug delivery system and methods
|
US10485785B2
(en)
*
|
2012-07-19 |
2019-11-26 |
Moriroku Chemicals Company, Ltd. |
Method for producing fine powder and the fine powder produced by the same
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
KR102499439B1
(ko)
|
2013-03-15 |
2023-02-13 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
CA2918369C
(en)
|
2013-07-18 |
2021-06-29 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
EP3411647A4
(de)
|
2016-02-05 |
2019-09-25 |
Tolmar Therapeutics, Inc. |
Belüftete abdeckplatte für eine anordnung von spritzen
|
USD908916S1
(en)
|
2018-06-19 |
2021-01-26 |
Tolmar Therapeutics, Inc. |
Syringe restrictor plate
|